<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-viruses-12-00276">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gomez-Roman</surname>
    <given-names>V.R.</given-names>
   </name>
   <name>
    <surname>Florese</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Montefiori</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Kalyanaraman</surname>
    <given-names>V.S.</given-names>
   </name>
   <name>
    <surname>Venzon</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Srivastava</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Barnett</surname>
    <given-names>S.W.</given-names>
   </name>
   <name>
    <surname>Robert-Guroff</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains</article-title>
  <source>J. Acquir. Immune Defic. Syndr.</source>
  <year>2006</year>
  <volume>43</volume>
  <fpage>270</fpage>
  <lpage>277</lpage>
  <pub-id pub-id-type="doi">10.1097/01.qai.0000230318.40170.60</pub-id>
  <pub-id pub-id-type="pmid">16940858</pub-id>
 </element-citation>
</ref>
